Literature DB >> 12270151

New Rev-transport inhibitor with anti-HIV activity from Valerianae Radix.

Nobutoshi Murakami1, Ying Ye, Motoyuki Kawanishi, Shunji Aoki, Nobuaki Kudo, Minoru Yoshida, Emi E Nakayama, Tatsuo Shioda, Motomasa Kobayashi.   

Abstract

Bioassay-guided separation by use of the fission yeast expressing NES of Rev, a HIV-1 viral regulatory protein, resulted in isolation of valtrate (1) as a new Rev-transport inhibitor from the nucleus to cytoplasm from Valerianae Radix. Valtrate (1) also inhibited the p-24 production of HIV-1 virus without showing any cytotoxicity against the host MT-4 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270151     DOI: 10.1016/s0960-894x(02)00624-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Nuclear export of proteins and drug resistance in cancer.

Authors:  Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal:  Biochem Pharmacol       Date:  2011-12-20       Impact factor: 5.858

2.  The CRM1 nuclear export receptor controls pathological cardiac gene expression.

Authors:  Brooke C Harrison; Charles R Roberts; David B Hood; Meghan Sweeney; Jody M Gould; Erik W Bush; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo.

Authors:  Joel G Turner; Jana Dawson; Michael F Emmons; Christopher L Cubitt; Michael Kauffman; Sharon Shacham; Lori A Hazlehurst; Daniel M Sullivan
Journal:  J Cancer       Date:  2013-09-10       Impact factor: 4.207

Review 4.  CRM1 Inhibitors for Antiviral Therapy.

Authors:  Cynthia Mathew; Reena Ghildyal
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

5.  Effects of Valeriana officinalis (Valerian) on tension-type headache: A randomized, placebo-controlled, double-blind clinical trial.

Authors:  Hossein Azizi; Asie Shojaii; Fataneh Hashem-Dabaghian; Mohammadreza Noras; Amirreza Boroumand; Bita Ebadolahzadeh Haghani; Roshanak Ghods
Journal:  Avicenna J Phytomed       Date:  2020 May-Jun

Review 6.  Spirocyclic Motifs in Natural Products.

Authors:  Evgeny Chupakhin; Olga Babich; Alexander Prosekov; Lyudmila Asyakina; Mikhail Krasavin
Journal:  Molecules       Date:  2019-11-17       Impact factor: 4.411

Review 7.  Structural Basis of Targeting the Exportin CRM1 in Cancer.

Authors:  Achim Dickmanns; Thomas Monecke; Ralf Ficner
Journal:  Cells       Date:  2015-09-21       Impact factor: 6.600

8.  Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenografts.

Authors:  Shuai Wang; Xiaohong Han; Jianfei Wang; Jiarui Yao; Yuankai Shi
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

Review 9.  Targeting nucleocytoplasmic transport in cancer therapy.

Authors:  Richard Hill; Bastien Cautain; Nuria de Pedro; Wolfgang Link
Journal:  Oncotarget       Date:  2014-01-15

10.  Compounds from the roots and rhizomes of Valeriana amurensis protect against neurotoxicity in PC12 cells.

Authors:  Qiuhong Wang; Changfu Wang; Yueming Zuo; Zhibin Wang; Bingyou Yang; Haixue Kuang
Journal:  Molecules       Date:  2012-12-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.